Mark Emmanuel CooperFollowMonash University1 paperORCID 0000-0001-7785-2488OpenAlexPapersEuropean Heart JournalHuman trial·29 SepPotential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetesGLP-1 receptor agonists
European Heart JournalHuman trial·29 SepPotential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetesGLP-1 receptor agonists